Back to Journals » Infection and Drug Resistance » Volume 12
Original Research
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,880 | Dovepress* | 7,329+ | 1,665 | 8,994 | |
PubMed Central* | 551 | 216 | 767 | ||
Totals | 7,880 | 1,881 | 9,761 | ||
*Since 1 April 2019 |
View citations on PubMed Central and Google Scholar